Cel-Sci
CVM
#9852
Rank
S$55.62 M
Marketcap
S$6.61
Share price
3.21%
Change (1 day)
-58.65%
Change (1 year)

Cel-Sci (CVM) - Total assets

Total assets on the balance sheet as of September 2025 : S$36.16 Million

According to Cel-Sci 's latest financial reports the company's total assets are S$36.16 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Cel-Sci - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-09-30S$36.32 M4.73%
2024-09-30S$34.68 M-16.83%
2023-09-30S$41.7 M-42.49%
2022-09-30S$72.52 M-29.62%
2021-09-30S$0.10 B86.28%
2020-09-30S$55.32 M44.89%
2019-09-30S$38.18 M-5.62%
2018-09-30S$40.45 M29.84%
2017-09-30S$31.15 M-8.23%
2016-09-30S$33.95 M-16.47%
2015-09-30S$40.64 M65.66%
2014-09-30S$24.53 M80.36%
2013-09-30S$13.6 M-31.11%
2012-09-30S$19.74 M-18.38%
2011-09-30S$24.19 M-51.35%
2010-09-30S$49.72 M-23.68%
2009-09-30S$65.15 M208.79%
2008-09-30S$21.1 M-31.06%
2007-09-30S$30.6 M99.65%
2006-09-30S$15.33 M193.29%
2005-09-30S$5.22 M-43.6%
2004-09-30S$9.26 M83.91%
2003-09-30S$5.03 M-24.83%
2002-09-30S$6.7 M-15.77%
2001-09-30S$7.95 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Curis
CRIS
S$35.5 M-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$0.57 B 1,485.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$115.78 B 320,051.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$1.11 B 2,985.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$51.19 B 141,455.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
S$247.66 B 684,720.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.87 B 5,089.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$7.92 M-78.08%๐Ÿ‡บ๐Ÿ‡ธ USA